Agios Pharmaceuticals
AGIO
AGIO
198 hedge funds and large institutions have $4.49B invested in Agios Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 83 increasing their positions, 47 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 178 → 198 (+20)
0.59% less ownership
Funds ownership: 96.38% → 95.79% (-0.59%)
5% less call options, than puts
Call options by funds: $24M | Put options by funds: $25.2M
Holders
198
Holding in Top 10
5
Calls
$24M
Puts
$25.2M
Top Buyers
| 1 | +$106M | |
| 2 | +$105M | |
| 3 | +$77.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$55.4M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$36.5M | |
| 3 | -$19.9M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$15.1M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$13M |